• α2-AR Agonism: From Signaling to OS Translation

  2026-08-28

  A translational framework for using 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine as an α2-adrenergic receptor agonist in immune rejection modulation and post-surgery osteosarcoma recurrence treatment research.

• Difloxacin HCl: Practical Research Workflows

  2026-08-28

  Difloxacin HCl supports two distinct bench applications: bacterial DNA gyrase inhibition for antimicrobial susceptibility testing and exploratory multidrug resistance reversal studies in human neuroblastoma models. This guide connects formulation, assay design, controls, and troubleshooting while clearly separating established product information from practical starting conditions.

• GPC3-HSP70 mRNA Nanovaccine for HCC

  2026-08-27

  Wang and colleagues developed an mRNA nanovaccine encoding tandem GPC3_127–136 CTL epitopes fused to HSP70 and delivered it with the tumor-binding peptide SP94-GGG-K18. In preclinical HCC models, vaccination increased antigen-specific CD8⁺ T-cell responses, while combination with anti-PD-L1 therapy produced stronger antitumor activity than either approach alone.

• ATM Inhibition Drives Metabolic Adaptation

  2026-08-27

  Huang and colleagues show that ATM suppression promotes macropinocytosis, enabling cancer cells to acquire extracellular nutrients under nutrient-poor conditions. The study identifies branched-chain amino acid dependence as a metabolic vulnerability and links DNA damage response signaling with nutrient scavenging and tumor-cell survival.

• NF-κB/miR-202-5p/HMGB2 in Septic AKI

  2026-08-26

  The reference study identifies an adaptive NF-κB/miR-202-5p/HMGB2 feedback loop that limits renal inflammation and tubular injury during sepsis-induced acute kidney injury. Its combination of cell-based perturbation, chromatin immunoprecipitation, reporter assays, and in vivo validation provides a mechanistic framework for studying inflammatory kidney damage.

• Ginsenoside Rg1: Neuroimmune Research Guide

  2026-08-26

  Ginsenoside Rg1 is a Panax-derived triterpene saponin studied as a neuroimmune modulation compound. In a mouse model, treatment reduced prolonged-isoflurane-associated behavioral, inflammatory, synaptic, and gut-barrier abnormalities through a regulatory T-cell-dependent process.

• Trypsin-Responsive Nanomedicine for Acute Pancreatitis

  2026-08-25

  This ACS Nano study introduces a biomimetic mesoporous organosilica nanoparticle that combines pancreatic acinar-cell targeting with trypsin-triggered degradation and on-demand delivery of the calcium chelator BAPTA-AM. In a mouse model of acute pancreatitis, the system reduced calcium overload, inflammatory and necrotic signaling, pancreatic enzyme abnormalities, and mortality, while also defining important limitations for translation beyond preclinical models.

• Dovitinib (TKI-258): Applied Cancer Workflows

  2026-08-25

  Build reproducible RTK-inhibition assays with Dovitinib, from solvent handling and phospho-signaling readouts to apoptosis and resistance studies. A data-driven library-design framework helps researchers use this multitargeted probe strategically rather than treating broad kinase activity as a limitation.

• GW4064: Practical FXR Assay Solutions

  2026-08-24

  Learn how GW4064 (SKU B1527) can help researchers design interpretable FXR activation, viability, proliferation, and cytotoxicity experiments. This scenario-based guide covers assay controls, preparation, data interpretation, and practical criteria for selecting a research-grade non-steroidal FXR agonist.

• ApexPrep DNA Plasmid Miniprep Kit for AML

  2026-08-24

  Build reproducible plasmid DNA extraction for cloning, sequencing, and functional AML assays with one alkaline-lysis workflow. The kit supports high- and low-copy vectors and can produce up to 30 μg of molecular biology grade plasmid DNA from a 1–5 mL bacterial culture.

• GSK 2837808A LDHA Inhibition Workflow

  2026-08-23

  GSK 2837808A offers a focused way to interrogate LDHA-driven lactate flux rather than blocking glycolysis globally. This practical workflow connects glucose consumption and extracellular lactate measurements with the NAT1-ENO1-lactate pathway while clearly separating validated hepatocellular carcinoma evidence from exploratory colorectal cancer applications.

• GCN2 Surveillance of Translation Termination

  2026-08-22

  Worner et al. identify GCN2 as a rapid surveillance kinase that detects compromised eukaryotic translation termination before ribosome collisions arise. Their acute eRF1-depletion and ribosome-profiling experiments show that GCN2-mediated eIF2α phosphorylation suppresses initiation, limiting termination-associated collisions and translation readthrough across mouse and human cell models.

• Calcitriol and Bone Remodeling: An Assay-First Guide

  2026-08-22

  Calcitriol, or 1,25-dihydroxy vitamin D3, is more than a vitamin D metabolite: it is a context-dependent regulator of VDR, cytokine, and cancer signaling. This assay-first guide uses new NFIA bone biology findings to improve experimental design, endpoint selection, and interpretation.

• CHIR-99021 in Neurovascular Stem Cell Models

  2026-08-21

  CHIR-99021 (CT99021) is a selective GSK-3 inhibitor that can turn Wnt pathway activity into a controllable experimental variable. This article explains how to evaluate it in advanced neuron–microglia–vascular models without confusing pluripotency, differentiation, and neurovascular maturation.

• GW4064: Non-Steroidal FXR Agonist Workflows

  2026-08-20

  GW4064 provides a selective way to activate FXR while separating receptor biology from broader bile acid and lipid perturbations. This practical guide connects reporter assays, hepatocyte efflux studies, and metabolic models with formulation, controls, and troubleshooting strategies.

8231 records 1/549 page Next 12345 下5页 Last page